Immunovant, Inc. (IMVT) insider trading

By person

18 insiders · 6 transactions

11.5×

Eric Venker holds 11.5 times base salary in stock. $7.33M of shares against $636.62K in salary for 2026.

Salary from the company's own proxy. The shares are what Eric Venker last reported holding, valued at $28.50, the price Common Stock was last bought or sold at on the open market here, on 28 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jay S Stout

Chief Technology Officer

—

$197.22K (3)

−$197.22K

198,937

0.0963%

$5.67M

+39.9%

Tiago Girao

Chief Financial Officer

—

$188.27K (1)

−$188.27K

234,192

0.1134%

$6.67M

—

Melanie Gloria

Chief Operating Officer

—

$71.85K (1)

−$71.85K

217,060

0.1051%

$6.19M

—

Tuyl Christopher Van

Chief Legal Officer

—

$42.54K (1)

−$42.54K

175,218

0.0848%

$4.99M

—

Roivant Sciences Ltd. entity

Director

—

113,317,007

54.86%

$3.23B

+42.0%

Peter Salzmann

Chief Executive Officer

—

1,178,191

0.5704%

$33.58M

+18.4%

Frank Torti

Director

—

1,009,228

0.4886%

$28.76M

+58.8%

Eva Renee Barnett

Chief Financial Officer

—

396,774

0.1921%

$11.31M

+18.3%

William L. Macias

Chief Medical Officer

—

357,353

0.1730%

$10.18M

−2.1%

Mark S. Levine

Chief Legal Officer

—

319,228

0.1546%

$9.10M

−1.1%

Eric Venker

Chief Executive Officer

—

257,075

0.1245%

$7.33M

—

Michael Geffner

Chief Medical Officer

—

217,958

0.1055%

$6.21M

+61.5%

George Migausky V

Director

—

137,251

0.0664%

$3.91M

+13.4%

Douglas J. Hughes

Director

—

134,653

0.0652%

$3.84M

+7.7%

Atul Pande

Director

—

116,731

0.0565%

$3.33M

+23.6%

Andrew J. Fromkin

Director

—

74,382

0.0360%

$2.12M

−25.6%

Jake Bauer

Director

—

38,896

0.0188%

$1.11M

—

Robert Graham Susman

Director

—

36,394

0.0176%

$1.04M

—

Immunovant, Inc.

What the insiders did Net selling

By person